Gravar-mail: Screening for Clonal Hematopoiesis as a Predictive Marker for Development of Therapy-Related Myeloid Neoplasia (t-MN) Following Neoadjuvant Therapy for Breast Cancer (S0012): A Southwest Oncology Group Study